Antiepileptic Medications for the Treatment of Epilepsy

Martha J. Morrell

doi:10.1055/s-2002-36645

Seminars in Neurology, Table of Contents

Semin Neurol 2002; 22(3): 247-258
DOI: 10.1055/s-2002-36645

Antiepileptic Medications for the Treatment of Epilepsy

Martha J. Morrell

Department of Neurology, The Neurological Institute, Columbia University, New York, New York

Abstract

ABSTRACT

Epilepsy is one of the most common neurological conditions encountered worldwide. The development of newer antiepileptic drugs (AEDs) has expanded over recent years, and the use of such drugs for indications other than epilepsy has also broadened. These factors insure that the majority of health care providers will be using an increasing number of AEDs in the care of their patients. Contained herein is a review of the mechanism of action of AEDs, individual drugs and their potential drug interactions, and general principles to guide the clinician in selection, implementation, and long-term monitoring of AEDs.

KEYWORD

Antiepileptic drug therapy - epilepsy

Full Text

References

REFERENCES

1 White H S, Woodhead J H, Wilcox K S, Stables J P, Kupferberg H J, Wolf H H. Discovery and preclinical development of antiepileptic drugs. In: Levy RH, Mattson RH, Meldrum BS, Perucca E, eds. Antiepileptic Drugs 5th ed. Philadelphia: Lippincott Williams & Wilkins 2001 0: 36-48
2 French J A, Dichter M A. New antiepileptic drug development: medical perspective. In: Levy RH, Mattson RH, Meldrum BS, Perucca E, eds. Antiepileptic Drugs 5th ed. Philadelphia: Lippincott Williams & Wilkins 2001 0: 49-57
3 Cramer J A, Fisher R, Menachem E B. New antiepileptic drugs: comparison of key clinical trials. Epilepsia . 1999; 40 590-600
4 Cereghino J J, Mitchell W G, Murphy J. Treating repetitive seizures with a rectal diazepam formulation. Neurology . 1998; 51 1274-1282
5 French J, Smith M, Faught E, Brown L. Practice advisory: the use of felbamate in the treatment of patients with intractable epilepsy. Neurology . 1999; 52 1540-1545
6 US Gabapentin Study Group Number 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology . 1993; 43 2292-2298
7 Chadwick D W, Anhut H, Greiner M J. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. Neurology . 1998; 51 1282-1288
8 Matsuo F, Bergen D, Faught E. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. US Lamotrigine Protocol 0.5 Clinical Trial Group. Neurology . 1993; 43 2284-2291
9 Dren A T, Moore E L, and the US Lamictal Protocol 0.5 Clinical Trial Group. Placebo-controlled, dose response evaluation of the efficacy and safety of lamotrigine as add-on therapy in epileptic outpatients with partial seizures. Epilepsia . 1993; 32 (suppl 3) 20
10 Loiseau P, Yuen A WC, Douche B, Menageer T, Arne-Bes M C. A randomized double-blind placebo-controlled cross-over add-on trial of LAMICTAL in patients with treatment-resistant partial seizures. Epilepsy Res . 1990; 7 136-145
11 Ramaratnam S, Marson A G, Baker G A. Lamotrigine add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev . 2000; (3) CD001909
12 Frank L M, Enlow T, Holmes G L. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia . 1999; 40 357-359
13 Steiner T J, Dellaportas C I, Findley L J. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia . 1999; 40 601-607
14 Motte J, Trevathan E, Arvidsson J F, Barrera M N, Mullens E L, Manasco P. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med . 1998; 339 851-852
15 Guberman A H, Besag F, Brodie M. Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia . 1999; 40 985-991
16 Loscher W, Honack D, Rundfeldt C. Antiepileptogenic effects of the novel AED levetiracetam (ucbL059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther . 1998; 284 474-479
17 Cereghino J J, Biton V, Abou-Khalil B, Dreifuss F, Gauer L J, Leppik I. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology . 2000; 55 236-242
18 Shorvon S D, Lowenthal A, Janz D, Bielen E, Loiseau P. Multicenter double-blind randomized, placebo controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsia . 2000; 41 1179-1186
19 Patsalos P N. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther . 2000; 85 77-85
20 Barcs G, Walker E B, Elger C E. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia . 2000; 41 1597-1607
21 Glauser T A, Nigro M, Sachdeo R. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. Neurology . 2000; 54 2237-2244
22 Schachter S C, Vazquez B, Fisher R S. Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology . 1999; 52 732-737
23 Richens A, Chadwick D W, Duncan J S. Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial. Epilepsy Res . 1995; 21 37-42
24 Sachdeo R C, Leroy R F, Krauss G L. Tiagabine therapy for complex partial seizures: a dose-frequency study. Arch Neurol . 1997; 54 595-601
25 Uthman B M, Rowan A J, Ahmann P A. Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial. Arch Neurol . 1998; 55 56-62
26 Biton V, Montouris G D, Ritter F. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology . 1999; 52 1330-1337
27 Abou-Khalil B. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group. Epilepsia . 2000; 41 (suppl 1) 72-76
28 Ritter F, Glauser T A, Elterman R D, Wyllie E. Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Epilepsia . 2000; 41 (suppl 1) 82-85
29 Jette N J, Marson A G, Kadir Z A, Hutton J L. Topiramate for drug resistant epilepsy. Cochrane Database Syst Rev . 2000; (2) CD001417
30 Glauser T A, Levisohn P M, Ritter F, Sachdeo R C. Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group. Epilepsia . 2000; 41 (suppl 1) 86-90
31 Chadwick D W, Marson A G. Zonisamide for drug-resistant partial epilepsy. Cochrane Database Syst Rev . 2000; (2) CD001416
32 Oommen K J, Mathews S. Zonisamide: a new antiepileptic drug. Clin Neuropharmacol . 1999; 22 192-200
33 Semah F, Picot M C, Adam C. Is the underlying cause of epilepsy a major prognostic factor for recurrence?. Neurology . 1998; 51 1256-1262
34 Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: a guideline for discontinuing antiepileptic drugs in seizure-free patients (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology . 1996; 47 600-602
35 Medical Research Council Antiepileptic Drug Withdrawal Study Group. Randomised study of antiepileptic drug withdrawal in patients in remission. Lancet . 1991; 337 1175-1180
36 Kwan P, Brodie M J. Effectiveness of first antiepileptic drug. Epilepsia . 2001; 42 1255-1260
37 Kwan P, Brodie M J. Early identification of refractory epilepsy. N Engl J Med . 2000; 342 314-319
38 Dlugos D J, Sammel M D, Strom B L, Farrar J T. Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology . 2001; 57 2259-2264
39 Karceski S, Morrell M, Carpenter D. The Expert Consensus Guideline Series: the treatment of epilepsy. Epilepsy Beh . 2001; 2 A1-A50
40 Holmes L B, Harvey E A, Coull B A. The teratogenicity of AED drugs. N Engl J Med . 2001; 344 1132-1138
41 Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology . 1998; 51 944-948
42 Zahn C A, Morrell M J, Collins S D, Labiner D M, Yerby M S. Management issues for women with epilepsy: a review of the literature. American Academy of Neurology Practice Guidelines. Neurology . 1998; 51 949-956
43 Yerby M S, Annegers J F, Bruni J. A North American registry for epilepsy and pregnancy: a unique public/private partnership of health surveillance. Epilepsia . 1998; 39 793-798